CEPI and Samsung Biologics collaborate to strengthen outbreak-ready vaccine production and global access

2026-02-03 - 13:38

OSLO, Norway and INCHEON, South Korea, Feb. 3, 2026 /PRNewswire/ — The Coalition for Epidemic Preparedness Innovations (CEPI) and Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced a partnership to strengthen vaccine manufacturing preparedness for future epidemic and pandemic threats. The collaboration will see Samsung Biologics join CEPI’s Vaccine Manufacturing